• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4704.0
  • ISIN : INE083D01012
87.73 -2 (-1.71%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    87.16

  • Today’s High

    89.94

  • Open

    89.94

  • Perv Close

    89.26

  • 52W Low

    60.00

  • 52W High

    102.99

Key Indicators

  • P/E(TTM)

    20.76

  • Mar.Cap (₹Cr.)

    139.67

  • Div & Yield %

    1.36

  • Book Value(₹)

    65.39

  • Debt-Equity Ratio

    -1.71

  • AGM Date

    22-Jul-2026

  • EPS

    4.24

  • P/E Ratio

    20.76

Financials Ratios

  • Debt-Equity Ratio

    1.99

  • Mar.Cap (₹Cr.)

    139.67

  • RONW (%)

    10.97

  • ROCE (%)

    11.29

Score Board

  • Equity (₹ in Cr.)

    15.92

  • BV (₹)

    65.40

  • Sales( ₹ in Cr.)

    310.80

  • NP (in Cr.)

    6.75

  • NP Var(%)

    -13.0

  • Div%

    12.0

  • CPS (₹)

    11.20

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    140.17

  • 52 Week High

    102.99

  • 52 Week Low

    60.00

  • Price BSE

    88.0

  • Price NSE

    88.00

  • Market Capital( in Cr.)

    140.17

  • P/C Ratio

    7.90

  • P/E Ratio

    20.80

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 302.50 338.54 303.10 280.37 249.31 170.67
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 302.50 338.54 303.10 280.37 249.31 170.67
Other Income 2.15 2.30 2.19 6.49 2.69 3.63
Stock Adjustments 7.08 1.06 17.90 4.85 -5.13 -3.32
Total Income 311.73 341.90 323.19 291.71 246.87 170.98
EXPENDITURE :            
Raw Materials 164.85 192.80 187.83 171.35 145.45 81.39
Power and Fuel Cost 8.29 8.73 6.87 5.37 4.70 4.68
Employee Cost 61.83 59.57 51.56 44.46 39.62 48.78
Other Manufacturing Expenses 10.70 12.95 20.20 14.64 9.12 7.07
Selling and Administration Expenses 33.21 32.27 26.21 21.64 15.44 17.59
Miscellaneous Expenses 0.42 1.56 1.90 4.35 3.24 0.82
Employee Benefit Expenses 61.83 59.57 51.56 44.46 39.62 48.78
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 279.30 307.89 294.56 261.82 217.57 160.34
Operating Profit 32.42 34.01 28.62 29.89 29.30 10.64
Interest 17.04 14.64 12.59 10.60 12.25 12.69
Gross Profit 15.38 19.37 16.03 19.29 17.05 -2.05
Depreciation 9.65 10.05 7.48 7.24 7.26 7.03
Profit Before Tax 5.73 9.32 8.55 12.05 9.79 -9.08
Current Tax -0.14 0.76 2.03 5.42 0.38 -0.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.93 0.84 0.39 -1.94 0.32 -0.03
Reported Net Profit 7.80 7.73 6.13 8.58 9.10 -8.90
Extraordinary Items 0.00 0.05 0.03 0.78 0.04 0.00
Adjusted Net Profit 7.80 7.68 6.10 7.80 9.06 -8.90
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.29
P & L Balance brought forward 42.90 36.74 42.37 35.27 26.18 36.79
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.91 1.57 1.56 1.48 0.00 1.42
P & L Balance carried down 48.79 42.90 46.94 42.37 35.27 26.17
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 12.00 12.00 10.00 10.00 10.00 0.00
Dividend Per Share(Rs) 1.20 1.20 1.00 1.00 1.00 0.00
Earnings Per Share-Unit Curr 4.90 4.89 3.90 5.79 6.14 -6.28
Earnings Per Share(Adj)-Unit Curr 4.90 4.89 3.90 5.79 6.14 -6.28
Book Value 62.07 58.74 61.21 58.28 52.88 46.53
Book Value(Adj)-Unit Curr 62.07 58.74 61.21 58.28 52.88 46.53

Shareholding Pattern

  • Promoter Group

    50.86%

  • Public Share Holding

    49.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 655,187 655,187.00 655,187 655,187
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 655,187 4.12 655,187 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,011,736 12.64 2,011,736 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,430,259 34.11 5,430,259 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,441,995 46.74 7,441,995 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 23,489 0.15 23,489 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 23,489 0.15 23,489 3
2] Non Institution
Bodies Corporate 87,945 0.55 87,844 47
Clearing Members 19,043 0.12 19,043 12
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 100 0.00 0 1
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,883,541 11.83 1,874,041 153
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 429,998 2.70 429,998 267
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,575,068 9.89 1,575,068 24
Individuals holding nominal share capital up to Rs. 1 lakh 3,656,505 22.97 3,577,685 14,451
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 141,719 0.89 141,719 1
Sub Total 7,800,201 48.99 7,711,680 14,960
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,920,872 100.00 15,832,351 14,974

Company Background

Bal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Bal Pharma Ltd
  • BSE Code : 4704.0
  • ISIN : INE083D01012

  • Incorporation Year

    1987

  • Registered Office

    21 & 22 Bommasandra Indl Area
    Hosur Road, Bangalore,
    Karnataka-560092

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Abdul Basith

  • Auditor

    SSJNB & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Bal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bal Pharma 88.04 304.65 302.50 20.76 9.42
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77